Results 301 to 310 of about 193,589 (341)
Some of the next articles are maybe not open access.
Bridging Therapy or IV Thrombolysis in Minor Stroke with Large Vessel Occlusion
Annals of Neurology, 2020Whether bridging therapy (intravenous thrombolysis [IVT] followed by endovascular treatment) is superior to IVT alone in minor stroke with large vessel occlusion (LVO) is unknown.
P. Seners +14 more
semanticscholar +1 more source
Clinical Science, 1976
1. A new method of destroying thrombi in blood vessels by ultrasound and simultaneously removing them is reported. 2. Experiments were performed in twenty dogs with artificial thrombi in the iliac and femoral arteries and veins. The length of the thrombi ranged from 4 to 5 cm and the age from 12 h to 10 days. The unit used consisted of a
A. Sobbe +5 more
openaire +3 more sources
1. A new method of destroying thrombi in blood vessels by ultrasound and simultaneously removing them is reported. 2. Experiments were performed in twenty dogs with artificial thrombi in the iliac and femoral arteries and veins. The length of the thrombi ranged from 4 to 5 cm and the age from 12 h to 10 days. The unit used consisted of a
A. Sobbe +5 more
openaire +3 more sources
Cardiologia (Rome, Italy), 1995
In this study, we assessed one particular aspect of the arrhythmogenic phenomena that occur during reperfusion secondary to thrombolysis, that is the therein involved metabolic mechanisms. The employed experimental model (isolated Langendorff-perfused rat heart) allowed us to distinguish which factor involved during ischemia, low coronary flow or low ...
B. Caro +3 more
openaire +3 more sources
In this study, we assessed one particular aspect of the arrhythmogenic phenomena that occur during reperfusion secondary to thrombolysis, that is the therein involved metabolic mechanisms. The employed experimental model (isolated Langendorff-perfused rat heart) allowed us to distinguish which factor involved during ischemia, low coronary flow or low ...
B. Caro +3 more
openaire +3 more sources
Archives of Neurology, 1996
On June6,1996, the Peripheral and Central Nervous System Drug Advisory Committee to the US Food and Drug Administration (FDA) voted 10 to 0 that tissue-type plasminogen activator (t-PA [lateplase]) is safe and effective therapy for acute ischemic stroke.
openaire +3 more sources
On June6,1996, the Peripheral and Central Nervous System Drug Advisory Committee to the US Food and Drug Administration (FDA) voted 10 to 0 that tissue-type plasminogen activator (t-PA [lateplase]) is safe and effective therapy for acute ischemic stroke.
openaire +3 more sources
International Journal of Stroke, 2019
Background Intravenous thrombolysis with alteplase within a time window up to 4.5 h is the only approved pharmacological treatment for acute ischemic stroke.
P. Ringleb +16 more
semanticscholar +1 more source
Background Intravenous thrombolysis with alteplase within a time window up to 4.5 h is the only approved pharmacological treatment for acute ischemic stroke.
P. Ringleb +16 more
semanticscholar +1 more source
British Journal of Haematology, 2009
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +3 more sources
SummaryThrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades.
openaire +3 more sources
Thrombosis and Haemostasis, 2005
SummaryCardiovascular diseases are a major cause of mortality in the developed world. Efficacy of thrombolysis plays an important role in the management of acute myocardial infarction and cerebral insult both in the acute event and in the long-term outcome of these patients.
Stefan, Pfaffenberger +6 more
openaire +2 more sources
SummaryCardiovascular diseases are a major cause of mortality in the developed world. Efficacy of thrombolysis plays an important role in the management of acute myocardial infarction and cerebral insult both in the acute event and in the long-term outcome of these patients.
Stefan, Pfaffenberger +6 more
openaire +2 more sources
2001
The pharmacological use of plasminogen activators is associated with symptomatic improvement in patients with coronary artery thrombosis, peripheral arterial occlusions, and thrombosis of the venous system. Based on prospective angiographic studies and planned programs (1, 2, 3, 4, 5), thrombolysis is the only approved treatment of acute ischemic ...
Gregory J. del Zoppo, Naohisa Hosomi
openaire +2 more sources
The pharmacological use of plasminogen activators is associated with symptomatic improvement in patients with coronary artery thrombosis, peripheral arterial occlusions, and thrombosis of the venous system. Based on prospective angiographic studies and planned programs (1, 2, 3, 4, 5), thrombolysis is the only approved treatment of acute ischemic ...
Gregory J. del Zoppo, Naohisa Hosomi
openaire +2 more sources
Ultrasonics, 2008
Ultrasound energy for thrombolysis dates back to 1976. Trubestein et al. demonstrated first in vitro that a rigid wire delivery low frequency ultrasound energy could disrupt clot. These investigators also showed that this system had potential for peripheral arterial clot dissolution in vivo in animal studies [G. Trubestein, C. Engel, F. Etzel, Clinical
Robert J, Siegel, Huai, Luo
openaire +2 more sources
Ultrasound energy for thrombolysis dates back to 1976. Trubestein et al. demonstrated first in vitro that a rigid wire delivery low frequency ultrasound energy could disrupt clot. These investigators also showed that this system had potential for peripheral arterial clot dissolution in vivo in animal studies [G. Trubestein, C. Engel, F. Etzel, Clinical
Robert J, Siegel, Huai, Luo
openaire +2 more sources
Thrombolysis for acute ischaemic stroke: current status and future perspectives
Lancet Neurology, 2023G. Tsivgoulis +7 more
semanticscholar +1 more source